MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Spasticity: Clinical features"

  • 2024 International Congress

    A Review of the Genetic Spectrum of Hereditary Spastic Paraplegias in the Middle East and North Africa Region

    M. Salari, S. Soleimani, F. Hojjati Pour (Tehran, Islamic Republic of Iran)

    Objective: To systematically review existing literature and collect data on Hereditary Spastic Paraplegias(HSP) in the Middle East and North Africa(MENA), aiming to assess the prevalence…
  • 2024 International Congress

    Ultrasound Assessment of Collagen Content in Contracted and Non-contracted Muscle Areas: A Comparative Study

    R. Bubnov, L. Kalika (Kyiv, Ukraine)

    Objective: The objective of this study was to evaluate the feasibility and reliability of ultrasound imaging as a method to estimate collagen content in contracted…
  • 2024 International Congress

    Mutation of the ATP5F1A gene associated with dystonia, spasticity, myoclonus, cognitive impairment and epilepsy – a rare case report of a patient

    M. Danis, G. Krastev, J. Necpal, R. Jech, M. Zech (Trnava, Slovakia)

    Objective: We present a patient with generalized dystonia with spasticity, craniofacial dysmorphism and myoclonus on the left upper limb due to mutation of the ATP5F1A…
  • 2024 International Congress

    Adult Onset Spastic Paraplegia in TUBB4A Leukodystrophy

    HJ. Kim, HJ. Ha, CY. Lee, JY. Yun (Seoul, Republic of Korea)

    Objective: Introduction: Leukodystrophies are primarily known as childhood diseases, but recent advances in genetic testing and brain imaging have led to an increase in reports…
  • 2023 International Congress

    Using wearable wireless technology to understand the natural history of adrenomyeloneuropathy in both clinic and home settings: 1-year follow-up in the CYGNET study

    C. Bergner, W. Koehler, J. Bonkowsky, C. Stephen, F. Eichler, L. Glenn, M. Engelen (Leipzig, Germany)

    Objective: To assess the feasibility of using wearable wireless motion sensors to quantify disease progression in men with adrenomyeloneuropathy (AMN) enrolled in the CYGNET natural…
  • 2023 International Congress

    Quantitative analysis of speech diadochokinetic rate in hereditary spastic paraplegia SPG3A

    V. Agrimaki, S. Siriopoulou, E. Zamba Papanicolaou, K. Christodoulou, K. Konstantopoulos (Kalamata, Greece)

    Objective: To analyze the dysarthria and speech diadochokinetic rate in a patient with hereditary spastic paraplegia (SPG3A). Background: Hereditary spastic paraplegias (HSP) are about 80…
  • 2023 International Congress

    Preparing for a clinical trial: a run-in natural history study in POLR3A-associated spastic ataxia with intronic mutations amenable to splice-modulating therapeutic approaches

    E. Jung, K. Manibarathi, I. Harting, S. Wolf, A. Aartsma-Rus, W. van Roon-Mom, M. Synofzik, H. Graessner, R. Schüle (Heidelberg, Germany)

    Objective: The aim of this study is the identification of progression and treatment response outcomes for POLR3A-associated spastic ataxia caused by the recurrent intronic c.1909+22G>A…
  • 2023 International Congress

    Early-onset spastic ataxia in a patient with prion (PRNP) p.Val180Ile mutation

    SM. Lee, DY. Yoo, TB. Ahn (Seoul, Republic of Korea)

    Objective: To broaden the clinical manifestation of PRNP gene mutation-related ataxia. Background: Genetic forms of prion diseases caused by PRNP mutation account for about 10-15%,…
  • 2023 International Congress

    Clinical and genetic characteristics of a cohort of 20 patients with confirmed biallelic pathogenic SPG7 mutations from the North West of England

    R. Heartshorne, J. Proudfoot-Jones, A. Barakat, M. Bonello (Liverpool, United Kingdom)

    Objective: To identify the prevalence and phenotype of patients with biallelic pathogenic SPG7 mutations Background: Spastic Paraplegia Type 7 (SPG7) is an autosomal recessive disorder…
  • 2023 International Congress

    Expanding the spectrum of Hereditary Spastic Paraplegia: An interesting Case .

    D. Joshi, S. Pattanayak, S. Parida, A. Kumar (Varanasi, India)

    Objective: We describe an interesting case of a young adult with a 5 year progressive history of spastic quadripareisis , cognitive decline, seizures and pseudobulbar…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 7
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley